Posted: Wed., Nov. 18, 1992

Carmike stock high on outlook for Yule B.O.

Yesterday Carmike Cinemas Inc. Class A shares saw heavy trading due to positive comments by Dean Witter Reynolds Inc. analyst Alan Gould.

Gould predicted to the brokerage sales force that the schedule of new movie releases such as "Bram Stoker's Dracula" and "Home Alone 2" should positively affect the company's fourth quarter.

Columbia Pictures' "Dracula" racked up $ 30.5 million in box office receipts when it opened this past weekend, a number much higher than expected.

Gould noted that the downside risk in the stock--which has remained flat for months--is $ 10.50 and that he has a target stock price of $ 16 by January and a 12-month target of $ 18.

Carmike Cinemas chief financial officer John Barwick noted that last weekend was a particularly good one for the company, with same-screen receipts up about 73% compared with the same weekend last year.

Gould also told the sales force of a rumor that the company might be buying about 60 new screens for 5 to 51/2 times cash flow, which he considers a "cheap price."

Barwick declined to comment on the rumor but says the company is always looking for new market opportunities.

Carmike owns and operates about 1,500 movie theaters, based mainly in smaller cities in the southern U.S.

Carmike shares closed up 75 cents yesterday at $ 12.50.


TALKBACK:

Have an opinion about this article? Be the first to comment


Fall TV Preview

Variety has everything you want to know about this fall's biggest shows.

Primetime Schedule for 2008-2009


Paramount Vantage


Variety interviews the Jonas Brothers at the Power of Youth gala in Los Angeles. ; Nick Jonas; target; Power of Youth; disney; video; variety; Jonas Brothers; The Jonas Brothers drive the kids wild at Variety and Target's Power of Youth event. ; The Jonas Brothers; target; Los Angeles; Power of Youth; video; variety;


© 2008 Reed Business Information, a division of Reed Elsevier Inc. All rights reserved. Use of this website is subject to its Terms & Conditions of Use. View our Privacy Policy.